BackImmix Biopharma Overview

Immix Biopharma Net Tangible Assets

Track Immix Biopharma's net tangible assets ($84M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$84.36M

Peer average

Loading

Immix Biopharma Net Tangible Assets History

Loading

Immix Biopharma vs. peers: Net Tangible Assets Comparison

Loading

Immix Biopharma Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Immix Biopharma (IMMX) FAQ

The latest net tangible assets for IMMX is $84M as of March 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Immix Biopharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, IMMX's net tangible assets moved from $0 to $84M. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Immix Biopharma's operating scale or balance-sheet position.

A net tangible assets figure of $84M for IMMX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IMMX's net tangible assets ($84M), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.